Brand names: Lamotrigine
3 interactions on record
Atazanavir/ritonavir ↓ lamotrigine Decreased lamotrigine AUC approximately 32%. (7, 12.3) · Protease inhibitors lopinavir/ritonavir and atazanavir/lopinavir decrease lamotrigine exposure by approximately 50% and 32%, respectively.
Source: FDA drug label - lamotrigine chewable dispersible
Lopinavir/ritonavir ↓ lamotrigine Decreased lamotrigine concentration approximately 50%. (7, 12.3) · Protease inhibitors lopinavir/ritonavir and atazanavir/lopinavir decrease lamotrigine exposure by approximately 50% and 32%, respectively.
Source: FDA drug label - lamotrigine chewable dispersible
Lopinavir/ritonavir ↓ lamotrigine Decreased lamotrigine concentration approximately 50%. Atazanavir/ritonavir ↓ lamotrigine Decreased lamotrigine AUC approximately 32%. (7, 12.3) · Protease inhibitors lopinavir/ritonavir and atazanavir/lopinavir decrease lamotrigine exposure by approximately 50% and 32%, respectively.
Source: FDA drug label - lamotrigine chewable dispersible